WASHINGTON — Patients with life-threatening conditions could soon have a new way to ask drug makers for medicines the Food and Drug Administration hasn’t yet approved, after the House on Tuesday voted to approve a version of “right-to-try” legislation.

The House passed the legislation 250-169. Now, the measure awaits a signature from President Trump, who repeatedly and passionately supported the measure and is expected to sign the legislation into law. The Senate had already passed this version of the legislation last August.